Insight into bisphosphonate-associated osteomyelitis of the jaw: pathophysiology, mechanisms and clinical management

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.7, Iss.4, 2008-07, pp. : 491-512

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bisphosphonate-associated risk of jaw osteonecrosis?

Reactions Weekly, Vol. 1, Iss. 1131, 2006-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Bisphosphonate-associated risk of jaw osteonecrosis?

Inpharma, Vol. 1, Iss. 1567, 2006-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Teriparatide Therapy for Bisphosphonate-Associated Osteonecrosis of the Jaw in an Elderly Japanese Woman with Severe Osteoporosis

By Iwamoto Jun

Clinical Drug Investigation, Vol. 32, Iss. 8, 2012-08 ,pp. : 547-553

Adis International

Access to resources Recommend Favorite

Risedronic acid: Bisphosphonate-associated osteonecrosis of the jaw, treated with teriparatide, in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1417, 2012-01 ,pp. : 39-39

Adis International

Access to resources Recommend Favorite

Obesity: Pathophysiology and Clinical Management

Current Medicinal Chemistry, Vol. 16, Iss. 4, 2009-02 ,pp. : 506-521

Bentham Science Publishers

Access to resources Recommend Favorite